
Overview
Servier Polska is a pharmaceutical company that focuses on three therapeutic areas: cardiometabolism, oncology, and neurology. It has developed worasydenib, a targeted molecular therapy for patients with grade 2 glioma with IDH gene mutations. The company employs 20,000 people and treats 100 million patients daily with its original medications.
Financials
Revenue history (in m)
Filing timeliness
Financial statements were filed on time, on average 40 days early. All were audited by a statutory auditor.
- 202525/03/2026
- 202414/04/2025
- 202310/04/2024
- 202213/04/2023
- 202112/04/2022
- 202021/12/2020
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
- Printing and service activities related to printing (18.1)
Offer
- Prescription medicines
- Oncology medicines
- Medicinal product information
- Drug safety monitoring
Websites
The company has 9 websites. Most of them run on WordPress. The sites are available in: Polish, English, German, Ukrainian, French and 8 more. The sites target these markets: United States, Ukraine, Switzerland, United Arab Emirates, Belgium and 15 more. Traffic on the sites is measured with Google Analytics.
- servier.plStrona główna – Servier PolskaWordPress 6.7Yoast SEOApache
- akademiaservier.plAkademia ServierWordPress 7.1Google AnalyticsGoogle Tag ManagerApache
- dbajoserce.plDbaj o serce - kampania społecznaWordPress 7.1Google AnalyticsGoogle Tag ManagerApache
Public procurement
9 tenders recorded as contractor: 2 national ($62,440) and 7 EU ($5,274).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Oct 14, 2026 | Supply of medicines for SP ZZOZ in Przasnysz | $184$184 | Samodzielny Publiczny Zespół Zakładów Opieki Zdrowotnej | |
| Aug 6, 2026 | Supply of medicinal products and medical devices, specialist dressings, items recently added to the formulary and medicines used in drug programmes – supplementary order | $551$551 | Wojewódzki Szpital Podkarpacki Im. Jana Pawła II w Krośnie | |
| Apr 3, 2026 | Supply of medicinal products for SP ZOZ in Łęczna | $2,505$2,505 | Samodzielny Publiczny Zakład Opieki Zdrowotnej w Łęcznej |
The company is the contractor in 2 public sector contracts, worth USD 20.27k in total. They were signed with 2 public buyers.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Sep 7, 2026 | Purchase of medicines | $170.00 | Samodzielny Publiczny Zespół Zakładów Opieki Zdrowotnej w Przasnyszu | |
| Jul 3, 2026 | Purchase of a medicinal product | $20,098 | Uniwersytecki Szpital Kliniczny Im. Jana Mikulicza-Radeckiego we Wrocławiu |
Trademarks
The company currently holds no active trademarks with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2002.
| Mark | Protected until | |
|---|---|---|
| MediBase | – |
Job offers
The company has its own careers page: servier.pl/dolacz-do-nas.
Authorized Representatives
Manner of representation
Each member of the management board has the right to represent the company individually.
Ownership
| Owner | Share value | Stake |
|---|---|---|
Biofarma S.a.s. | $5,657,549.97 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 1998-04-01.
- 12 1840 0007 2210 0000 0819 0110
80 1030 1335 0000 0008 2206 3500- 69 1840 0007 2210 0000 0700 1319
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Janssen-Cilag Polska sp. z o.o. | $323,933,929.12 | janssen.pl | ||
| Takeda Pharma sp. z o.o. | $246,400,594.27 | takeda.com | ||
| Chiesi Poland sp. z o.o. | $87,762,158.97 | chiesi.com | ||
| Synoptis Pharma sp. z o.o. | $79,311,000.88 | synoptispharma.pl | ||
| Polfarmex S.A. | $73,543,379.32 | polfarmex.pl | ||
| Solinea sp. z o.o. | $72,245,607.27 | solinea.pl | ||
| Medac Gesellschaft Fur Klinische Spezialpraparate M.B.H. Branch (foreign co.) | $55,460,856.07 | medac.pl | ||
| SUN-Farm sp. z o.o. | $51,063,341.52 | sunfarm.pl | ||
| Tactica Pharmaceuticals sp. z o.o. | $28,095,609.42 | tactica.pl | ||
| Glenmark Pharmaceuticals sp. z o.o. | $26,934,644.29 | glenmarkpharma.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-07-16 | Switch to PKD 2025 (5 PKD 2007 codes → 10 PKD 2025 codes) | |
| 2022-11-21 | Address change (Jana Kazimierza 10, 01-248, Warszawa → Ul. Burakowska 14, 01-066, Warszawa) | |
| 2017-05-30 | PKD change (Removed: 15 codes; Added: 1 code) | |
| 2010-09-17 | Switch to PKD 2007 (14 PKD 2004 codes → 19 PKD 2007 codes) | |
| 2005-07-20 | Address change (Sienna 75, 00-833, Warszawa → Jana Kazimierza 10, 01-248, Warszawa) |
FAQ
Last updated: 2026-10-07